Gupta R N, Lew M
J Chromatogr. 1985 Nov 8;344:221-30. doi: 10.1016/s0378-4347(00)82022-8.
A liquid chromatographic procedure for the determination of mexiletine or tocainide in human plasma is described. Plasma, after the addition of a homologue of mexiletine or of tocainide, is extracted with dichloromethane. The extract is evaporated and reconstituted in a non-aqueous o-phthalaldehyde--mercaptoethanol reagent. An aliquot of the solution is chromatographed on a reversed-phase Ultrasphere-octyl column. The peaks are detected by fluorescence (lambda ex = 350 nm and lambda em = 445 nm). The fluorescent derivatives of the drugs and internal standards are stable at room temperature and give symmetrical single peaks. Use of fluorescamine as a reagent to prepare fluorescent derivatives of mexiletine and tocainide prior to chromatography is also evaluated.
本文描述了一种用于测定人血浆中美西律或妥卡尼的液相色谱法。加入美西律或妥卡尼的同系物后,血浆用二氯甲烷萃取。萃取液蒸发后,用非水邻苯二甲醛 - 巯基乙醇试剂复溶。取一份溶液在反相Ultrasphere - 辛基柱上进行色谱分析。通过荧光检测峰(激发波长λex = 350 nm,发射波长λem = 445 nm)。药物和内标的荧光衍生物在室温下稳定,呈现对称的单峰。还评估了使用荧光胺作为试剂在色谱分析前制备美西律和妥卡尼荧光衍生物的情况。